Page last updated: 2024-09-04

zm 230487 and bwa 4c

zm 230487 has been researched along with bwa 4c in 2 studies

Compound Research Comparison

Studies
(zm 230487)
Trials
(zm 230487)
Recent Studies (post-2010)
(zm 230487)
Studies
(bwa 4c)
Trials
(bwa 4c)
Recent Studies (post-2010) (bwa 4c)
170074016

Protein Interaction Comparison

ProteinTaxonomyzm 230487 (IC50)bwa 4c (IC50)
Polyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)0.1976
Arachidonate 5-lipoxygenase-activating proteinHomo sapiens (human)0.11
Prostaglandin G/H synthase 1Homo sapiens (human)3.2
Prostaglandin G/H synthase 2Homo sapiens (human)3.2

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ammon, HP; Brungs, M; Safayhi, H; Sailer, ER; Schneider, N; Steinhilber, D; Werz, O1
Fischer, L; Rådmark, O; Steinhilber, D; Szellas, D; Werz, O1

Other Studies

2 other study(ies) available for zm 230487 and bwa 4c

ArticleYear
A test system for leukotriene synthesis inhibitors based on the in-vitro differentiation of the human leukemic cell lines HL-60 and Mono Mac 6.
    Naunyn-Schmiedeberg's archives of pharmacology, 1997, Volume: 356, Issue:4

    Topics: Arachidonate 5-Lipoxygenase; Benzeneacetamides; Cell Differentiation; Chromatography, High Pressure Liquid; Enzyme Induction; HL-60 Cells; Humans; Hydroxamic Acids; In Vitro Techniques; Indoles; Leukemia, Myeloid; Leukotriene Antagonists; Leukotrienes; Pyrans; Quinolones; Triterpenes; Tumor Cells, Cultured; Up-Regulation

1997
Phosphorylation- and stimulus-dependent inhibition of cellular 5-lipoxygenase activity by nonredox-type inhibitors.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2003, Volume: 17, Issue:8

    Topics: Arachidonate 5-Lipoxygenase; Arsenites; Benzeneacetamides; Bridged Bicyclo Compounds; Calcimycin; Calcium; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; HeLa Cells; Humans; Hydroxamic Acids; Lipoxygenase Inhibitors; Mitogen-Activated Protein Kinases; Mutation, Missense; Neutrophils; Peroxides; Phloroglucinol; Phosphorylation; Pyrans; Quinolines; Quinolones; Sodium Chloride; Sodium Compounds; Terpenes

2003